Goldman Sachs Group Inc Utah Medical Products Inc Transaction History

Goldman Sachs Group Inc

  • $596 Billion
  • Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Utah Medical Products Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 14,286 shares of UTMD stock, worth $754,443. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,286
Previous 14,286 -0.0%
Holding current value
$754,443
Previous $800,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$56.04 - $64.17 $27,739 - $31,764
-495 Reduced 3.35%
14,286 $800,000
Q4 2024

Feb 11, 2025
BUY
$60.9 - $68.52 $473,680 - $532,948
7,778 Added 111.07%
14,781 $908,000
Q3 2024

Nov 14, 2024
BUY
$65.79 - $75.08 $256,449 - $292,661
3,898 Added 125.54%
7,003 $468,000
Q2 2024

Aug 13, 2024
SELL
$65.92 - $70.99 $302,902 - $326,199
-4,595 Reduced 59.68%
3,105 $207,000
Q1 2024

May 15, 2024
SELL
$68.14 - $84.23 $1.83 Million - $2.26 Million
-26,812 Reduced 77.69%
7,700 $547,000
Q4 2023

Feb 13, 2024
SELL
$77.07 - $87.05 $496,639 - $560,950
-6,444 Reduced 15.73%
34,512 $2.91 Million
Q3 2023

May 14, 2024
BUY
$83.86 - $99.16 $540,393 - $638,987
6,444 Added 18.67%
40,956 $3.52 Million
Q3 2023

Nov 14, 2023
BUY
$83.86 - $99.16 $8,386 - $9,916
100 Added 0.24%
40,956 $3.52 Million
Q2 2023

May 14, 2024
SELL
$87.76 - $99.95 $228,527 - $260,269
-2,604 Reduced 5.99%
40,856 $3.81 Million
Q2 2023

Aug 14, 2023
SELL
$87.76 - $99.95 $228,527 - $260,269
-2,604 Reduced 5.99%
40,856 $3.81 Million
Q1 2023

May 14, 2024
BUY
$87.14 - $100.3 $214,800 - $247,239
2,465 Added 6.01%
43,460 $4.12 Million
Q1 2023

May 11, 2023
BUY
$87.14 - $100.3 $214,800 - $247,239
2,465 Added 6.01%
43,460 $4.12 Million
Q4 2022

May 14, 2024
BUY
$82.45 - $101.88 $412 - $509
5 Added 0.01%
40,995 $4.12 Million
Q4 2022

Feb 13, 2023
BUY
$82.45 - $101.88 $412 - $509
5 Added 0.01%
40,995 $4.12 Million
Q3 2022

May 14, 2024
BUY
$80.73 - $95.26 $826,029 - $974,700
10,232 Added 33.27%
40,990 $3.5 Million
Q3 2022

Nov 10, 2022
BUY
$80.73 - $95.26 $826,029 - $974,700
10,232 Added 33.27%
40,990 $0
Q2 2022

May 14, 2024
SELL
$81.49 - $90.28 $305,913 - $338,911
-3,754 Reduced 10.88%
30,758 $2.64 Million
Q2 2022

Aug 15, 2022
BUY
$81.49 - $90.28 $118,730 - $131,537
1,457 Added 4.97%
30,758 $2.64 Million
Q1 2022

May 16, 2022
SELL
$86.04 - $99.89 $345,794 - $401,457
-4,019 Reduced 12.06%
29,301 $2.63 Million
Q4 2021

Feb 14, 2022
SELL
$88.84 - $124.71 $92,660 - $130,072
-1,043 Reduced 3.04%
33,320 $3.33 Million
Q3 2021

Nov 10, 2021
BUY
$84.89 - $97.16 $2.92 Million - $3.34 Million
34,363 New
34,363 $3.19 Million

Others Institutions Holding UTMD

# of Institutions
108
Shares Held
2.23M
Call Options Held
0
Put Options Held
0
View Full List

About UTAH MEDICAL PRODUCTS INC

UTMD Quotes by TradingView
  • Ticker UTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 3,625,200
  • Market Cap $191M
  • Description
  • Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO u...
More about UTMD
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email